Deguenther Mark S MD - 35213 Birmingham, AL

Business Name: Deguenther Mark S MD
Categorized In: Doctors
Address: 880 Montclair Road # 377, Birmingham, AL 35213
Phone Number: (205) 930-0920
Contact Person: Mark Deguenther
Website Address: urologycentersalabama.com
NAICS Code: 6211110
SIC Code: 8011
Business Type: B2C (Business to Consumer)
Employee #: 1 to 4
Location Type: Single Location
Annual Revenue ($): $500.000 to $999.999
Share This Business:
Similar Businesses: Kelley Weddington MD - Birmingham, AL 35213
Kelley W Bishop MD - Birmingham, AL 35213
Goldstein Allan R MD - Birmingham, AL 35213
Bell C Douglas MD - Birmingham, AL 35213
Reddington Natalie T DO - Birmingham, AL 35213
Paul Christopher MD - Birmingham, AL 35213
Kelly Arthur G MD - Birmingham, AL 35213
Hazelring Cooper G MD - Birmingham, AL 35213
Reyes Nathaniel A MD - Birmingham, AL 35213
Swillie Connie M MD - Birmingham, AL 35213
Stidham Jeremy V MD - Birmingham, AL 35213
Pappas Louis S MD - Birmingham, AL 35213
Moore Paula D MD - Birmingham, AL 35213
Miklic Margaret S MD - Birmingham, AL 35213
Kirchner John S MD - Birmingham, AL 35213
Briggs Elizabeth MD - Birmingham, AL 35213
Lozano Richard L MD - Birmingham, AL 35213
Harvey Jimmie H MD - Birmingham, AL 35213
Hughes Robert E MD - Birmingham, AL 35213
Dailey Jr Douglas W MD - Birmingham, AL 35213

Deguenther Mark S MD provides professional Doctors from its single location at the coordinates 33.521627,-86.733275.

The company offers B2C variables under the SIC code 8011 and NAICS code 6211110, while making an annual revenue of $500.000 to $999.999 and hiring a total of 1 to 4 employees.

Founded in 0, the company can now be visited at 880 Montclair Road # 377, Birmingham, Alabama 35213 or contacted through representative Mark Deguenther at (205) 930-0920.

For frequently asked questions and further inquiries about professional Doctors, get to know more about Deguenther Mark S MD through its company website at urologycentersalabama.com. Engage with this business on its social media platforms through on Twitter and on Facebook.